PHARMACEUTICAL PRICING POLICY AND CONTROL– INDIAN PERSPECTIVE

Authors

  • RENGANATHAN R ProfessorSchool of ManagementSASTRA University
  • VIJAYABANU C
  • SRINIVASAKUMAR V
  • VIJAY ANAND V

DOI:

https://doi.org/10.22159/ajpcr.2016.v9i6.14461

Abstract

ABSTRACT

Pharmaceutical sector is playing a vital role towards the wellness of the people and economic development of India. The innovation, development, production and marketing of medicines are accountable to pharmaceutical industry. Drugs and pharmaceuticals, healthcare delivery, medical devices among others come under the purview of healthcare sector. It is the duty of the Government to ensure the availability of the lifesaving drugs at reasonable prices by means of considering the interest of both the producers and the buyers. In order to safeguard the public health, National Pharmaceutical Pricing Authority (NPPA) is the watchdog in India, which controls the prices of drugs.

Keywords: Pharmaceutical sector, Price, Drugs, Regulator,NPPA,DPCO

Author Biography

RENGANATHAN R, ProfessorSchool of ManagementSASTRA University

Professor

School of Management

SASTRA University

References

REFERENCES

Available from: http://www.ibef.org/industry/pharmaceutical-india.aspx referred on 11-05-

April Maguire, 2015. 6 Different Pricing Strategies: Which Is Right for Your Business? http://quickbooks.intuit.com/r/pricing-strategy/6-different-pricing-strategies-which-is-right-for-your-business/ referred on 11-05-16

Divya Rajagopal, 2016, Policy bumps may hit pharmaceutical market’s dream run, ET Bureau | 22 Mar, 2016, The Economic Times referred on 11-05-16

Eric Fry, 2015, Big pharma won’t stay silent in drug pricing debate for longâ€, http://fortune.com/2015/10/22/big-pharma-wont-stay-silent-in-drug-pricing-debate-for-long/

, 6,7,8. Available from: http://www.ibef.org/industry/healthcare-india.aspx#sthash.Heb8S1UI.dpuf referred on 13-05-16

Available from: http://www.ibef.org/industry/pharmaceuticalindia.aspx#sthash.hSUomUqF.dpuf referred on 13-05-16

Available from:

http://www.ibef.org/industry/pharmaceutical-india.aspx#sthash.I1nbxhAO.dpuf referred 0n 13-05-16

Vidya Krishnan, 2016, Intellectual Property Rights policy may hinder drug access, The Hindu dated May 13, 2016

Available from; All you need to know about the new IPR Policy, The Hindu, dated- May 14, 2016 15:40 IST,http://www.thehindu.com/business/all-you-need-to-know-about-the-intellectual-property-rights-policy/article8600530.ece

Bhupendra Singh,Message from Chairman, The National Pharmaceutical Pricing Authority (NPPA). Available from: http://www.nppaindia.nic.in/. referred on 13-05-16

Available from: http://www.businessdictionary.com/definition/pricing.html. Referred on 8/4/16

-19, 22-23. Available from: http://www.thehindu.com/business/govt-forms-committee-to-review-drug-pricing-policy/article7830066.ece, 1/11/15. Referred on 11/4/16

,21. Availablefrom: .http://www.tapanray.in/indias-drug-pricing-policy-absurd-unreasonable-and-irrational-supreme-court/. Referred on 11/5/16

-23. Available from: http://www.thehindu.com/business/govt-forms-committee-to-review-drug-pricing-policy/article7830066.ece, 1/11/15. Referred on 11/4/16

-27. Available from: http://www.nppaindia.nic.in/. Referred on 11.4.16

Available from: http://www.mbaskool.com/business-concepts/marketing-and-strategy-terms/7285-market-based-pricing.html. Referred on 27/5/16

,31-32. Rama Subramanian, Nikhil Mutyal, Emma Nechamkin, 2014, ‘Are market-based pharmaceutical price controls the new reality in India? Available from: https://www.simon-kucher.com/sites/default/files/

Availble from: http://cdsco.nic.in/WriteReadData/NLEM-2015/Recommendations.pdf Referred on 28/4/16

,32. Rama Subramanian, Nikhil Mutyal, Emma Nechamkin, 2014, ‘Are market-based pharmaceutical price controls the new reality in India? Available from: https://www.simon-kucher.com/sites/default/files/

ET Bureau | 23 Nov, 2015, 06.21PM IST. Available from: http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/national-pharmaceutical-pricing-authority-exempts-price-controls-for-3-insulins-of-wockhardt/articleshow/49894230.cms

About 200 more drugs under price controlâ€, Business Standard, BS Reporter | New Delhi March 14, 2016. Available from: http://www.business-standard.com/article/companies/about-200-more-drugs-under-price-control-116031401171_1.html

the pharmaletter, India’s NPPA brings many more drug formulations under price control, 15-03-2016, http://www.thepharmaletter.com/article/india-s-nppa-brings-many-more-drug-formulations-under-price-control

-40. Anku Goyal,NPPA caps prices of 48 more drugs,May 11, 2016. BTvIn.com

Referred on 9th July 2016, http://www.btvin.com/article/read/industry/5649/nppa-caps-prices-of-48-more-drugs

Published

2016-11-01

How to Cite

RENGANATHAN R, VIJAYABANU C, SRINIVASAKUMAR V, and VIJAY ANAND V. “PHARMACEUTICAL PRICING POLICY AND CONTROL– INDIAN PERSPECTIVE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 6, Nov. 2016, pp. 305-8, doi:10.22159/ajpcr.2016.v9i6.14461.

Issue

Section

Original Article(s)